![The-Landscape-for-Lipid-Nanoparticle-Based-Genomic-Medicines-Cover](https://web-assets.bcg.com/dims4/default/fe56e75/2147483647/strip/true/crop/1620x1620+630+0/resize/146x146!/format/webp/quality/90/?url=http%3A%2F%2Fboston-consulting-group-brightspot.s3.amazonaws.com%2F1d%2F35%2F37069a744752ac9c3f8e54866db3%2Fthe-landscape-for-lipid-nanoparticle-based-genomic-medicines-cover.jpg)
The Landscape for Lipid-Nanoparticle-Based Genomic Medicines
LNPs are well-positioned to support the emerging field of genomic medicines, for which safety and efficient in vivo delivery has been a key challenge.
Malvika Verma Imran Ozer Wen Xie Ryan Gallagher Alexandra Teixeira Michael Choy
LNPs are well-positioned to support the emerging field of genomic medicines, for which safety and efficient in vivo delivery has been a key challenge.